-
Oncologist Is Humbled, Inspired by His Patients
In honor of Black History Month, PanCAN is celebrating the contributions of the Pancreatic Cancer community’s Black supporters and the amazing ways they’re making a difference for pancreatic cancer patients. Read the interview with Marcus Noel, MD.
Uncategorized
-
Off Our Chests: John Marshall, MD, and Liza Marshall Recount Her TNBC Journey
Dr. John Marshall and his wife, Liza, recount the challenging journey of Liza’s triple-negative breast cancer diagnosis and how Dr. Marshall’s career as a gastrointestinal oncologist played into the caregiving process.
Category: News
-
Targeted Talks: Gut Microbiome
In season 2, episode 2 of Targeted Talks, Cathy Eng, MD, speaks with Benjamin Weinberg, MD, about the gut microbiome, and how the presence of certain microbiota impact the onset and intensity of disease as well as the potential response to certain treatments.
Category: News
-
Off Our Chests
Learn more about the new book by Dr. John Marshall and his wife Liza Marshall. In a joint statement they explained, “we wrote the book to help others learn about what a diagnosis of cancer means for a patient, for a family, for a caregiver, and for an oncologist so that those who walk that path together might find both support and insight to help light the way.”
Category: News
-
Ask the Doctor- Interview with Dr. John L. Marshall
In an interview with Cancer Wellness Magazine, Dr. John L. Marshall shares his thoughts on the rising rates of early-onset colorectal cancers.
Category: News
-
ASCO’s recognition of molecular profiling in GI cancers as the “Advance of the Year”
According to Dr. Louis M. Weiner, Professor and Director of Georgetown Lombardi Comprehensive Cancer Center, “ASCO’s recognition of molecular profiling in GI cancers as the ‘Advance of the Year’ validates the mission and work of Lombardi’s Ruesch Center for the Cure of GI Cancers. Since its founding over 10 years ago, the Ruesch Center has prioritized the science of precision medicine through education, building collaborative research networks, and dedicated funding all supporting precision medicine in GI cancers. ASCO’s selection of our collective progress reinforces and re-energizes us all. We are indebted to John Marshall, MD for his vision, energy, and wisdom in bringing this important initiative to life and then nurturing it.”
Category: News
-
Precision Medicine, Targeted Therapy, and ZIP Codes: ASCO GI 2021
The Doximity Op-Med, authored by Former Ruesch Center faculty member Mohamed Salem, provides an excellent review of a selection of ASCO GI-presented research. This article highlights his ongoing study, in collaboration with The Ruesch Center’s Marion Hartley and Georgetown’s Kristi Graves, into socioeconomic status and survival outcomes in patients with gastrointestinal cancers.
Category: News
-
Factors to Consider When Prescribing 3L Colorectal Cancer Therapy
John L. Marshall, MD discusses factors to consider when prescribing third line therapy for colorectal cancer in a discussion with Targeted Oncology. According to Marshall, there are 3 or more medications to choose from when considering third line therapy including regorafenib (Stivarga) and TAS-102 (trifluridine and tipiracil, brand name Lonsurf. This space is also constantly evolving, with promising new combinations from Lonsurf.
Category: News
-
Interview with Dr. John Marshall and Dr. Tony Shields on MI FOLFOXai™
In this interview Dr. Marshall and Dr. Shields discuss the findings of their paper and how we can better predict which metastatic colorectal cancer patients will benefit from first-line FOLFOX+BV followed by FOLFIRI+BV or vice versa.
Category: News
-
Ruesch Center Targets Gastrointestinal Cancers
While her husband received treatment, Jeanne Ruesch saw firsthand the dishearteningly protracted pace of gastrointestinal cancer research. She was inspired by the care that she and her husband received from oncologist John Marshall, MD, but at the same time recognized a gaping need for a better understanding of GI cancers and how to treat them.
Category: News